FMC (FMC) Q3 2026 Earnings Call Transcript
FMC reported Q3 2026 earnings, including a $672M EBITDA impact from commercial actions. Revenue was $106M, with underlying sales at $745M, below guidance. Adjusted EBITDA was negative $559M. The company is changing its North America business model and adjusting prices to reduce channel inventory. Q4 revenue is expected to be $1.04B-$1.14B, with adjusted EBITDA between $210M-$230M.
How this was made
The 30-second read
Why it matters
The earnings release introduces new material numbers and guidance, likely prompting a sell‑off.
Market read
The disclosed charge and guidance downgrade are fresh, material information that can affect FMC's stock price immediately.
What to watch
Potential cost reductions from manufacturing footprint changes and new product launches may offset short‑term pain.
Background
FMC reported Q3 2026 results with a large non‑cash charge related to inventory pricing adjustments and provided lowered Q4 guidance.
Ticker impact
Q3 2026 earnings call disclosed a $672M EBITDA impact from commercial actions and lowered Q4 guidance.
likely downward pressure as investors price in the $672M charge and reduced Q4 outlook
The disclosed charge and guidance downgrade are fresh, material information that can move the stock immediately.
Market effects
Agricultural chemicals sector may see broader concerns over pricing models and inventory pressures.
North America growers could face higher input costs, affecting regional ag‑input demand.
FMC's pricing changes could influence global ag‑chemical pricing dynamics.
Counterpoint
If the inventory adjustments succeed, future quarters could see improved margins and a rebound.
Key entities
- CompanyFMC Corporation
US‑listed agricultural chemicals producer.
